To determine whether changes in insulin receptors follow acute myocardial infarction, 10 non-diabetic patients were studied on admission to a coronary care unit and 24 h later. Erythrocyte insulin receptors were 86 (50-406) per cell [median (range)] initially and increased significantly to 203 (73-714). Maximum percent specific binding and 50% inhibition of tracer binding did not change significantly. Decreased receptor number after myocardial infarction may contribute to insulin resistance in the acute phase.
Fasting hyperglycaemia and/or glucose intolerance frequently follows acute myocardial infarction in non-diabetic subjects. 1-3 The precise mechanism for disordered carbohydrate metabolism is unclear. In patients with cardiogenic shock complicating infarction insulin secretion is impaired," but in uncomplicated myocardial infarction hyperinsulinaemia in the presence of a normal or raised blood glucose concentration is widely reported.?" Several mechanisms have been postulated to explain this insulin resistance, including excessive catabolic hormone response," hypothalamic factors," decreased hepatic extraction of insulin, 1 and precipitation of diabetes mellitus."
In order to see whether changes in insulin receptors may playa part in producing insulin resistance, we have studied non-diabetic subjects following acute myocardial infarction.
Materials and methods
Ten patients (eight men, two women; age range 37--67 years) were studied following admission to a coronary care unit. Acute myocardial infarction was confirmed in all patients by a typical history of cardiac pain plus electrocardiographic changes and a rise in serum aspartate transaminase. No patient had clinical evidence of left ventricular failure or cardiogenic shock at the time of the study. None of the patients was taking diuretics on admission but four with a previous history of cardiac pain were on beta-blockers. Both female patients were post-menopausal and no patient had a first degree relative with diabetes mellitus. All patients were less than 120% ideal body weight. 10 Haemoglobin concentration was greater than 14 g/loo mL and reticulocyte counts were less than 2% in all patients.
Whole blood (20 mL) was collected into a lithium/heparin tube within 21 h of the onset of chest pain for measurement of insulin receptors. This was repeated 25-45 h after the onset of pain. The interval between samples in individual patients was 23-24 h.
Erythrocytes were separated by centrifugation through Ficoll/hypaque'P (Pharmacia, Upsalla, Sweden);'! The final pellet was resuspended in Tris buffer (pH 8,0) (Sigma, Dorset, UK) to give a final concentration of erythrocytes of 4·4 x 10 9/mL. Porcine insulin (Actrapid, Novo Laboratories, Basingstoke , Hampshire, UK) was iodinated to a specific activity of 220-260 IlCilIlg using a modification of the chloramine-T method. 12 Following purification of 125 1_ monoiodoinsulin on a Sephadex G50® column (Sephadex, Pharmacia Ltd, Milton Keynes, UK), binding to human erythrocytes was determined b~incubating 400 ilL cell suspension, 26 pg 1 51-iodoinsulin and 0-10 6 ng/mL unlabelled porcine insulin, for 2 h at 15°C. 13 Duplicate 100 ul, aliquots of cell suspension were placed in pre-chilled microfuge tubes (Alpha Laboratories, Hampshire, UK) containing 200 ul, Tris buffer with 100 ul, di-n-butylphthalate (density 1·044) (Sigma, Dorset, UK). Cell-bound and free insulin were separated by centrifugation in a Beckman microfuge B (Beckman-Riic Ltd, High Wycombe, Bucks, UK) at 4 cC for 2-5 min. The cut tip of the tube containing the pellet was counted in a Hewlett-Packard Autogamma 500® counter (Hewlett-Packard Ltd, Wokingham, Berks, UK).
Non-specific binding, defined as radioactivity bound to erythrocytes in the presence of 10 6 nglmL unlabelled insulin, was subtracted from bound insulin at each concentration of unlabelled insulin and ranged from 11 to 20%. Intra-assay coefficient of variation for duplicate samples from normal subjects is 5% in our laboratory. Scatchard analysis 14 was used to derive receptor number and maximal insulin binding. Least-squares regression was used to determine the line of best fit which was extrapolated to the abscissa. Competition curves were plotted to determine 50% inhibition of tracer binding.
Results are given as median (range). Significant differences were sought using the Wilcoxon test for paired data."
Results
Myocardial infarction was confirmed by electro-0·08 cardiographic changes (six anterior, three inferior and one anterolateral infarcts) and a rise in plasma aspartate transaminase to a maximum of 52-790 ulL.
Scatchard plots were derived for each blood sample and the average plot for the first and second samples is shown in Fig. 1 . The 95% confidence limits of the intercept on the abscissa were 1·9-7·2 nglmL (first sample) and 5·4-15·2 nglmL (second sample). Receptor number within 21 h of infarction was 50-406 per cell (median 86). Receptor number in the second sample was 73-714 per cell (median 203). Nine of the 10 patients showed an increase in the number of erythrocyte insulin receptors between samples and in the remaining patient the number was unchanged. The mean percentage increase was 158% (range (}-364%). The increase in receptor number was statistically significant (P<O·Ol).
Maximum percent specific binding was 7·9'}'o (3·(}-12·5%) in the first sample and 5·8% (2'(}-11'3%) in the second sample (not significant), while 50% inhibition of tracer binding was 4·6 (2,4-12,0) nglmL and 7·9 (2·0-35·0) nglmL respectively (not significant).
At the time of the first receptor measurement blood glucose concentration was 5·1-13·0 mmol/L and at the second sample was 5·5-9·5 mmollL. 
Discussion
Insulin produces metabolic effects by firstly binding to specific cell membrane receptors. 16 Changes in the number and affinity of these receptors occur in a number of diseases, including obesitir,17· 18 diabetes mellitus/ 8 ,. 19 acromegaly, 0 chronic liver disease'" and certain insulin resistant syndromes.F Changes in receptor number have not previo~sly b.een described following myocardial infarction, although hyperglycaemia with hype.rinsulinaemia is well recognised in uncomphcated myocardial infarction.
. Circulating insulin concentration is a major factor regulating insulin receptor number.P Reduction in receptor number occurs in hyperinsulinaemic disorders/" (down-regulation) and increased number in hypoinsulinaemic states." In the present study we have not measured circulating insulin levels. Considerable difficulties would arise in the interpretation of a single insulin measurement on admission with variable lengths of fasting between patients, vomiting in some, but not all patients, and administration of opiate analgesia.
We have observed significantly lower erythrocyte insulin receptor number in patients within 24 h of myocardial infarction than 24 h later. The results for the first sample are significantly lower (P<O·OOl) than in normal controls age-, sex-and weight-matched in our laboratory (318±1l6 receptors per erythrocyte). It seems likely that these changes are effected through circulating insulin levels, although an effect of drugs used after myocardial infarction, particularly opiate analgesia, cannot be ruled out.
Ideally, insulin receptors should be measured on specific target cells such as muscle or adipocyte. Clearly, ethical considerations may prevent this, and monocytes/" and erythrocytes 25 • 27 have been extensively used. Changes in these cells are considered to parallel changes in target tissues, although this has been disputed.j" A further problem with the use of erythrocytes is the inability of these cells to synth~sise protein. Since the insulin receptor. IS a glycoprotein.r? it is difficult to expl.am~ow receptor number can increase. Following binding of the hormone to its receptor, however, the complex is internalised." and may be degraded 31 or the hormone degraded and the , n receptor retuned to the cell membrane. Changes in the rates of degradation and recycling provide one means of modifying cell surface numbers. Insulin receptor numbers on erythrocytes and by extension on other tissues are decreased within 24 h of a myocardial infarction and may play some part in associated insulin resistance.
